These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

54 related items for PubMed ID: 11998508

  • 1. Soy extract reduces prostate cancer growth in mice, cell culture.
    Urol Nurs; 2001 Dec; 21(6):411-2. PubMed ID: 11998508
    [No Abstract] [Full Text] [Related]

  • 2. Genistein potentiates the radiation effect on prostate carcinoma cells.
    Hillman GG, Forman JD, Kucuk O, Yudelev M, Maughan RL, Rubio J, Layer A, Tekyi-Mensah S, Abrams J, Sarkar FH.
    Clin Cancer Res; 2001 Feb; 7(2):382-90. PubMed ID: 11234894
    [Abstract] [Full Text] [Related]

  • 3. Genistein induces cell growth inhibition in prostate cancer through the suppression of telomerase activity.
    Ouchi H, Ishiguro H, Ikeda N, Hori M, Kubota Y, Uemura H.
    Int J Urol; 2005 Jan; 12(1):73-80. PubMed ID: 15661057
    [Abstract] [Full Text] [Related]

  • 4. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo.
    Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM.
    Cancer Res; 2000 Sep 15; 60(18):5165-70. PubMed ID: 11016644
    [Abstract] [Full Text] [Related]

  • 5. The G gamma / T-15 transgenic mouse model of androgen-independent prostate cancer: target cells of carcinogenesis and the effect of the vitamin D analogue EB 1089.
    Perez-Stable CM, Schwartz GG, Farinas A, Finegold M, Binderup L, Howard GA, Roos BA.
    Cancer Epidemiol Biomarkers Prev; 2002 Jun 15; 11(6):555-63. PubMed ID: 12050097
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
    Jagadeesh S, Kyo S, Banerjee PP.
    Cancer Res; 2006 Feb 15; 66(4):2107-15. PubMed ID: 16489011
    [Abstract] [Full Text] [Related]

  • 13. Genistein inhibits matrix metalloproteinase type 2 activation and prostate cancer cell invasion by blocking the transforming growth factor beta-mediated activation of mitogen-activated protein kinase-activated protein kinase 2-27-kDa heat shock protein pathway.
    Xu L, Bergan RC.
    Mol Pharmacol; 2006 Sep 15; 70(3):869-77. PubMed ID: 16772519
    [Abstract] [Full Text] [Related]

  • 14. Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis.
    Kyprianou N, Benning CM.
    Cancer Res; 2000 Aug 15; 60(16):4550-5. PubMed ID: 10969806
    [Abstract] [Full Text] [Related]

  • 15. Prostate cancer treatment is enhanced by genistein in vitro and in vivo in a syngeneic orthotopic tumor model.
    Wang Y, Raffoul JJ, Che M, Doerge DR, Joiner MC, Kucuk O, Sarkar FH, Hillman GG.
    Radiat Res; 2006 Jul 15; 166(1 Pt 1):73-80. PubMed ID: 16808622
    [Abstract] [Full Text] [Related]

  • 16. Genistein inhibits proliferation and in vitro invasive potential of human prostatic cancer cell lines.
    Santibáñez JF, Navarro A, Martínez J.
    Anticancer Res; 1997 Jul 15; 17(2A):1199-204. PubMed ID: 9137471
    [Abstract] [Full Text] [Related]

  • 17. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587).
    Dionne CA, Camoratto AM, Jani JP, Emerson E, Neff N, Vaught JL, Murakata C, Djakiew D, Lamb J, Bova S, George D, Isaacs JT.
    Clin Cancer Res; 1998 Aug 15; 4(8):1887-98. PubMed ID: 9717816
    [Abstract] [Full Text] [Related]

  • 18. Effect of mammalian lignans on the growth of prostate cancer cell lines.
    Lin X, Switzer BR, Demark-Wahnefried W.
    Anticancer Res; 2001 Aug 15; 21(6A):3995-9. PubMed ID: 11911282
    [Abstract] [Full Text] [Related]

  • 19. [Chemotherapy of carcinoma of the prostate and testis: experimental study in vivo and in vitro].
    Okada K, Kanamaru H, Yoshiki T, Hashimura T, Nishimura K, Hida S, Nishio Y, Oishi K, Yoshida O, Yamauchi T.
    Hinyokika Kiyo; 1988 Nov 15; 34(11):1911-6. PubMed ID: 2468265
    [Abstract] [Full Text] [Related]

  • 20. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
    Sweeney P, Karashima T, Kim SJ, Kedar D, Mian B, Huang S, Baker C, Fan Z, Hicklin DJ, Pettaway CA, Dinney CP.
    Clin Cancer Res; 2002 Aug 15; 8(8):2714-24. PubMed ID: 12171905
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.